We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Plexus (PLXS) Q3 Earnings and Revenues Surpass Estimates
Read MoreHide Full Article
Plexus Corp (PLXS - Free Report) reported third-quarter fiscal 2022 adjusted earnings of $1.33 per share, which surged 34% year over year. The Zacks Consensus Estimate stood at $1.10 per share.
Revenues of $981 million topped the consensus mark by 8.2% and increased 20.5% year over year. The top-line performance gained from an improving demand environment and new program ramps amid global supply chain disruptions.
In the reported quarter, Asia-Pacific revenues rose 31%, while that from Europe and the Middle East and Africa and the Americas increased 10.5% and 7.5%, respectively.
During the quarter, Plexus won 47 manufacturing contracts during the quarter, worth $201 million in annualized revenues when fully ramped into production. Trailing four-quarter manufacturing wins totaled more than $1 billion in annualized revenues.
Industrial revenues were up 22% year over year to $454 million, contributing 46% to total revenues.
Healthcare/Life Sciences revenues jumped 24% from the year-ago quarter’s levels to $401 million. The segment contributed 41% to total revenues.
Aerospace/Defense revenues increased 6.8% year over year to $126 million, contributing 13% to total revenues.
The top 10 customers of the company accounted for 56% of net revenues.
Operating Details
Gross profit on a GAAP basis increased 26.4% year over year to $93.6 million. The gross margin expanded 40 basis points (bps) to 9.5%.
Selling and administrative expenses (4.5% of revenues) increased 20.9% from the year-ago quarter to $44.1 million.
Plexus reported an adjusted operating income of $49.6 million, up 31.8% year over year. Adjusted operating margin expanded 50 bps to 5.1%.
Balance Sheet & Cash Flow
As of Jul 2, 2022, Plexus had cash & cash equivalents worth $276.6 million compared with $307.9 million as of Apr 2, 2022.
As of Jul 2, 2022, the company had long-term debt and finance lease obligations, net of the current portion of $184.7 million compared with $186.1 million as of Apr 2, 2022.
In the quarter under review, the cash flow provided by operations was $21.2 million. The company reported a free cash outflow of $42 million. The company repurchased 11.7 million shares at an average price of $79.27 per share. With this bulk of repurchases, Plexus completed the $50 million share repurchase program authorized by the board of directors on Aug 11, 2021
Guidance
For fourth-quarter fiscal 2022, revenues are projected between $980 million and $1.020 billion.
GAAP operating margin is expected to be between 4.7% and 5.2%. GAAP earnings are expected in the range of $1.19-$1.35 per share, including 22 cents of stock-based compensation expenses.
The Zacks Consensus Estimate for BMI’s 2022 earnings is pegged at $2.30 per share, up 7% in the past 60 days. Badger Meter’s earnings beat the Zacks Consensus Estimate in three of the preceding four quarters, with the average being 12.6%. Shares of BMI have lost 8.7% of their value in the past year.
The Zacks Consensus Estimate for Synopsys 2022 earnings is pegged at $8.67 per share, unchanged in the past 60 days. The long-term earnings growth rate is anticipated to be 19.6%.
Synopsys earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 2.7%. Shares of SNPS have increased 23.8% in the past year.
The Zacks Consensus Estimate for Aspen’s fiscal 2022 earnings is pegged at $5.49 per share, rising 0.4% in the past 60 days. The long-term earnings growth rate is anticipated to be 16.3%.
Aspen’s earnings beat the Zacks Consensus Estimate in three of the last four quarters, the average being 4%. Shares of AZPN have grown 34.8% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Plexus (PLXS) Q3 Earnings and Revenues Surpass Estimates
Plexus Corp (PLXS - Free Report) reported third-quarter fiscal 2022 adjusted earnings of $1.33 per share, which surged 34% year over year. The Zacks Consensus Estimate stood at $1.10 per share.
Revenues of $981 million topped the consensus mark by 8.2% and increased 20.5% year over year. The top-line performance gained from an improving demand environment and new program ramps amid global supply chain disruptions.
In the reported quarter, Asia-Pacific revenues rose 31%, while that from Europe and the Middle East and Africa and the Americas increased 10.5% and 7.5%, respectively.
During the quarter, Plexus won 47 manufacturing contracts during the quarter, worth $201 million in annualized revenues when fully ramped into production. Trailing four-quarter manufacturing wins totaled more than $1 billion in annualized revenues.
Plexus Corp. Price, Consensus and EPS Surprise
Plexus Corp. price-consensus-eps-surprise-chart | Plexus Corp. Quote
Market Sector Details
Industrial revenues were up 22% year over year to $454 million, contributing 46% to total revenues.
Healthcare/Life Sciences revenues jumped 24% from the year-ago quarter’s levels to $401 million. The segment contributed 41% to total revenues.
Aerospace/Defense revenues increased 6.8% year over year to $126 million, contributing 13% to total revenues.
The top 10 customers of the company accounted for 56% of net revenues.
Operating Details
Gross profit on a GAAP basis increased 26.4% year over year to $93.6 million. The gross margin expanded 40 basis points (bps) to 9.5%.
Selling and administrative expenses (4.5% of revenues) increased 20.9% from the year-ago quarter to $44.1 million.
Plexus reported an adjusted operating income of $49.6 million, up 31.8% year over year. Adjusted operating margin expanded 50 bps to 5.1%.
Balance Sheet & Cash Flow
As of Jul 2, 2022, Plexus had cash & cash equivalents worth $276.6 million compared with $307.9 million as of Apr 2, 2022.
As of Jul 2, 2022, the company had long-term debt and finance lease obligations, net of the current portion of $184.7 million compared with $186.1 million as of Apr 2, 2022.
In the quarter under review, the cash flow provided by operations was $21.2 million. The company reported a free cash outflow of $42 million. The company repurchased 11.7 million shares at an average price of $79.27 per share. With this bulk of repurchases, Plexus completed the $50 million share repurchase program authorized by the board of directors on Aug 11, 2021
Guidance
For fourth-quarter fiscal 2022, revenues are projected between $980 million and $1.020 billion.
GAAP operating margin is expected to be between 4.7% and 5.2%. GAAP earnings are expected in the range of $1.19-$1.35 per share, including 22 cents of stock-based compensation expenses.
Zacks Rank & Stocks to Consider
Plexus currently has a Zacks Rank #3 (Hold).
Some other top-ranked stocks from the broader technology sector worth consideration are Synopsys (SNPS - Free Report) , Aspen Technology (AZPN - Free Report) and Badger Meter (BMI - Free Report) . BMI sports a Zacks Rank #1 (Strong Buy) while Synopsys and Aspen carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for BMI’s 2022 earnings is pegged at $2.30 per share, up 7% in the past 60 days. Badger Meter’s earnings beat the Zacks Consensus Estimate in three of the preceding four quarters, with the average being 12.6%. Shares of BMI have lost 8.7% of their value in the past year.
The Zacks Consensus Estimate for Synopsys 2022 earnings is pegged at $8.67 per share, unchanged in the past 60 days. The long-term earnings growth rate is anticipated to be 19.6%.
Synopsys earnings beat the Zacks Consensus Estimate in the last four quarters, the average being 2.7%. Shares of SNPS have increased 23.8% in the past year.
The Zacks Consensus Estimate for Aspen’s fiscal 2022 earnings is pegged at $5.49 per share, rising 0.4% in the past 60 days. The long-term earnings growth rate is anticipated to be 16.3%.
Aspen’s earnings beat the Zacks Consensus Estimate in three of the last four quarters, the average being 4%. Shares of AZPN have grown 34.8% in the past year.